Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2023 Filed Feb 24, 2023 22:36 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 1,114 | $3.00 | $3,343.11 |
DisclosureSEC source: 0001567619-23-003767 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 113,096 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 22:36 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 3,394 | $3.00 | $10,185.39 |
DisclosureSEC source: 0001567619-23-003767 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,600 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 21, 2023 Filed Mar 2, 2023 16:36 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 5,586 | $3.00 | $16,763.59 |
DisclosureSEC source: 0001567619-23-004210 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,131 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:24 UTC |
Rodriguez SusanChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000643 · doc1.xml · derivative · entry 2 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:24 UTC |
Rodriguez SusanChief Commercial Officer
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000643 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,717 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:23 UTC |
Williams Laura AChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000640 · doc1.xml · derivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:23 UTC |
Williams Laura AChief Medical Officer
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000640 · doc1.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,200 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:27 UTC |
Blanks RobertSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000649 · doc1.xml · derivative · entry 2 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:27 UTC |
Blanks RobertSee Remarks
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000649 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,363 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:25 UTC |
Renz Justin AChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000645 · doc1.xml · derivative · entry 2 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 16:25 UTC |
Renz Justin AChief Financial Officer
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000645 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,045 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 116,250 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000652 · doc1.xml · derivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 116,250 Underlying: Common Stock · 116,250 shares Expires 2033-01-05 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000652 · doc1.xml · derivative · entry 4 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 25,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000652 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 114,210 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:29 UTC |
Rosenbaum David P.Chief Development Officer
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000652 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,994 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:28 UTC |
Felsch Robert OraSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000651 · doc1.xml · derivative · entry 2 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:28 UTC |
Felsch Robert OraSee Remarks
|
GrantCommon Stock | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000651 · doc1.xml · nonDerivative · entry 1 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,418 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:26 UTC |
GRAMMER ELIZABETH ASee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000647 · doc1.xml · derivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:26 UTC |
GRAMMER ELIZABETH ASee Remarks
|
GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000647 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,868 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 1,124,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000639 · doc1.xml · derivative · entry 4 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,124,000 Underlying: Common Stock · 1,124,000 shares Expires 2033-01-05 F4 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:22 UTC |
RAAB MICHAELDirector · President & CEO
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000639 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 909,461 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:15 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 3,303 | $1.95 | $6,438.54 |
DisclosureSEC source: 0001567619-22-020848 · doc1.xml · nonDerivative · entry 3 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,717 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:15 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 22 | $1.95 | $42.79 |
DisclosureSEC source: 0001567619-22-020848 · doc1.xml · nonDerivative · entry 2 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,020 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:15 UTC |
Rodriguez SusanChief Commercial Officer
|
SaleCommon Stock | 131 | $1.94 | $254.38 |
DisclosureSEC source: 0001567619-22-020848 · doc1.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,042 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:13 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 1,193 | $1.95 | $2,325.51 |
DisclosureSEC source: 0001567619-22-020844 · doc1.xml · nonDerivative · entry 3 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,200 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:13 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 33 | $1.95 | $64.19 |
DisclosureSEC source: 0001567619-22-020844 · doc1.xml · nonDerivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,393 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:13 UTC |
Williams Laura AChief Medical Officer
|
SaleCommon Stock | 15 | $1.94 | $29.12 |
DisclosureSEC source: 0001567619-22-020844 · doc1.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,426 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:12 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 1,405 | $1.95 | $2,738.77 |
DisclosureSEC source: 0001567619-22-020842 · doc1.xml · nonDerivative · entry 3 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,363 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:12 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 26 | $1.94 | $50.48 |
DisclosureSEC source: 0001567619-22-020842 · doc1.xml · nonDerivative · entry 2 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,768 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:12 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 33 | $1.94 | $64.07 |
DisclosureSEC source: 0001567619-22-020842 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,794 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:14 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 1,443 | $1.95 | $2,812.84 |
DisclosureSEC source: 0001567619-22-020846 · doc1.xml · nonDerivative · entry 2 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,045 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 16:14 UTC |
Renz Justin AChief Financial Officer
|
SaleCommon Stock | 61 | $1.94 | $118.43 |
DisclosureSEC source: 0001567619-22-020846 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,488 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 471 | $1.95 | $918.12 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 6 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 88,885 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 2 | $1.95 | $3.89 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 5 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 89,356 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 11 | $1.94 | $21.34 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 4 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 89,358 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 1,405 | $1.95 | $2,738.77 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 3 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,994 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 33 | $1.95 | $64.25 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,399 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:18 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 26 | $1.94 | $50.48 |
DisclosureSEC source: 0001567619-22-020850 · doc1.xml · nonDerivative · entry 1 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,432 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 1,193 | $1.95 | $2,325.51 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,868 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 20 | $1.95 | $38.90 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,061 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC |
GRAMMER ELIZABETH ASee Remarks
|
SaleCommon Stock | 29 | $1.94 | $56.30 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,081 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:14 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 5,936 | $1.95 | $11,571.04 |
DisclosureSEC source: 0001567619-22-020847 · doc1.xml · nonDerivative · entry 3 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,461 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:14 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 121 | $1.94 | $234.97 |
DisclosureSEC source: 0001567619-22-020847 · doc1.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,397 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:14 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 162 | $1.94 | $314.28 |
DisclosureSEC source: 0001567619-22-020847 · doc1.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 665,518 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 17, 2022 Filed Nov 17, 2022 21:07 UTC |
MOTT DAVID MDirector
|
PurchaseCommon Stock | 567,000 | $1.76 | $1,000,641.60 |
DisclosureSEC source: 0001567619-22-020554 · doc1.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,166,765 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 per share to $1.78 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 16:06 UTC |
Blanks RobertSee Remarks
|
SaleCommon Stock | 100,000 | $1.50 | $150,000.00 |
DisclosureSEC source: 0001567619-22-018357 · doc1.xml · nonDerivative · entry 1 Blanks Robert · CIK 0001815433 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,827 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 01, 2022 Filed Sep 1, 2022 23:04 UTC |
Rosenbaum David P.Chief Development Officer
|
SaleCommon Stock | 3,000 | $0.92 | $2,760.30 |
DisclosureSEC source: 0001567619-22-016959 · doc1.xml · nonDerivative · entry 2 Rosenbaum David P. · CIK 0001611311 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 89,369 F2 · ownership.nature: The shares are directly held by the Reporting Person's wife. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:03 UTC |
Williams Laura AChief Medical Officer
|
PurchaseCommon Stock | 3,000 | $0.62 | $1,856.40 |
DisclosureSEC source: 0001567619-22-016957 · doc1.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,441 F1 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 19:04 UTC |
Renz Justin AChief Financial Officer
|
PurchaseCommon Stock | 3,000 | $0.62 | $1,856.40 |
DisclosureSEC source: 0001567619-22-016958 · doc1.xml · nonDerivative · entry 1 Renz Justin A · CIK 0001466562 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,549 F1 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:05 UTC |
Felsch Robert OraSee Remarks
|
PurchaseCommon Stock | 3,000 | $0.62 | $1,856.40 |
DisclosureSEC source: 0001567619-22-016960 · doc1.xml · nonDerivative · entry 1 Felsch Robert Ora · CIK 0001917819 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,418 F1 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.